For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $2.12 in the prior trading day, Autolus Therapeutics plc ADR (NASDAQ: AUTL) closed at $2.05, down -3.30%. In other words, the price has decreased by -$3.30 from its previous closing price. On the day, 2.75 million shares were traded.
Ratios:
Our goal is to gain a better understanding of AUTL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.99 and its Current Ratio is at 9.21. In the meantime, Its Debt-to-Equity ratio is 0.84 whereas as Long-Term Debt/Eq ratio is at 0.83.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on November 18, 2024, Upgraded its rating to Buy and sets its target price to $7.60 from $7 previously.
On November 15, 2024, Redburn Atlantic Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $13.
On November 09, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $10.Deutsche Bank initiated its Buy rating on November 09, 2023, with a $10 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 16 ’24 when Martin Pule bought 698,741 shares for $4.23 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 60.55 while its Price-to-Book (P/B) ratio in mrq is 1.47.
Stock Price History:
Over the past 52 weeks, AUTL has reached a high of $5.00, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is 31.09%, while the 200-Day Moving Average is calculated to be -19.56%.
Shares Statistics:
A total of 266.14M shares are outstanding, with a floating share count of 240.33M. Insiders hold about 9.70% of the company’s shares, while institutions hold 54.13% stake in the company.
